Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DP-b99 phase 3 trial in acute ischemic stroke
NL-OMON34979Phase 3Active, not recruiting
- Sponsor
- D-Pharm
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing DP-b99 with Placebo (2 arms). Primary endpoint: Modified Rankin Scale distribution at Day 90. Started Jul 2010; status: active, not recruiting.
02
Drugs
DP-b99
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NL-OMON34979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34979.